Glucosamine: Clinical Evidence & Substantiation Summary
What Is Glucosamine?
Glucosamine is an amino sugar and a natural component of cartilage. It is one of the most widely used supplements for joint health, with decades of clinical research and a complex evidence profile that varies by form and outcome measure.
Mechanism of action: Glucosamine serves as a substrate for glycosaminoglycan and proteoglycan synthesis in cartilage. It inhibits IL-1β and TNF-α mediated cartilage degradation, reduces MMP activity, and supports chondrocyte metabolism. It may also have mild anti-inflammatory effects independent of NSAID pathways.
Clinical Evidence Summary
Below are 3 key clinical studies on Glucosamine. Nutra Comp analyses 78+ studies in its full clinical evidence report.
Glucosamine sulfate for osteoarthritis: a Cochrane review
Population: 25 RCTs, 4,963 participants
Key finding: Crystalline glucosamine sulfate (1,500 mg/day) improved pain and function over 6 months+, with effects reaching clinical significance. Generic glucosamine showed weaker results.
Glucosamine and all-cause mortality
Population: 495,077 UK Biobank participants
Key finding: Regular glucosamine use was associated with 15% lower all-cause mortality (HR 0.85, 95% CI 0.82–0.88) and 18% lower cardiovascular mortality, independent of confounders.
Glucosamine sulfate vs HCl: comparative efficacy
Population: 15 RCTs
Key finding: Glucosamine sulfate showed significantly greater pain reduction than glucosamine HCl (p=0.01), supporting the sulfate form as the evidence-backed choice.
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Glucosamine
Includes all 78+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is glucosamine FDA approved?
Glucosamine is a dietary supplement under DSHEA. In Europe, crystalline glucosamine sulfate (Dona®) is approved as a prescription medication for osteoarthritis.
What form works best?
Crystalline glucosamine sulfate shows the strongest evidence. Glucosamine HCl has weaker results in meta-analyses. The sulfate form at 1,500 mg/day is the evidence-backed choice.
What dosage is used in clinical studies?
The standard evidence-based dose is 1,500 mg/day of glucosamine sulfate, taken as a single dose or divided into three 500 mg doses.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist